Adult Stem Cell Therapy Helps Hawaiian’s Heart December 13, 2007
Posted by TheraVitae in : Press Releases , trackbackStem Cell Treatment Doubles Patient’s Heart Functio
Honolulu, Hawaii 12/13/2007 03:30 AM GMT (TransWorldNews)
Patrick Moran, 68, of Hawaii, stated his heart function has doubled since receiving adult stem cell therapy in Thailand in March, 2006. His ejection fraction (a measure of the heart’s pumping function) has gone up from 20-22% before stem cell therapy to between 45-49%, more than 18 months after his stem cell treatment.
Patrick’s health had deteriorated after suffering a heart attack in 1993. He also had a quadruple bypass surgery in 2003. Suffering from congestive heart failure, he rarely got a good night’s sleep, had trouble walking up stairs, and had frequent bouts of angina.
Patrick has always been a firm believer in taking action. “I didn’t always want to react to something negative happening to my heart. I wanted to take positive action and that was when we heard about Theravitae.”
Theravitae is an adult stem cell therapy company that specializes in treating heart patients suffering from angina, congestive heart failure, coronary artery disease and cardiomyopathy with the patient’s own adult stem cells using their Vescell technology.
Patrick and his wife Sharon arrived in Bangkok, Thailand in March, 2006. “We were treated in the highest manner possible. Before arrival, we felt apprehensive, but we were made to feel right at home. Theravitae, the doctors, the nurses were very professional in every way. We felt a strong spiritual bond with everyone involved in the process.
Patrick’s own adult stem cells were implanted in a simple procedure, very similar to an angioplasty.
These days, Patrick is feeling much better after his stem cell treatment. “I have seen steady improvement since receiving stem cell therapy. I’m not sure how a 68 year old male is supposed to feel like, but I feel somewhat normal now. Using a person’s own stem cells to heal them and extend their life is wonderful. God is blessing this kind of work.”
About TheraVitae:
TheraVitae is a private, multinational company focused on using stem cells from the patient’s own blood in order to treat a variety of disorders, especially cardiovascular diseases. The company has developed a proprietary stem cell technology, ‘VesCell’, that is currently being used by hospitals in Thailand and Singapore to treat patients with heart disease and peripheral artery disease.
VesCell — A Natural Treatment for Heart Disease and Peripheral Arterial Disease (PAD)
The body has natural ways of healing itself and the cardiovascular system is no exception. Angiogenic Cell Precursors (ACPs) originate in bone marrow and then circulate in the blood vessels. To manufacture VesCell, TheraVitae expands a small number of ACPs harvested from about 250cc of blood into a therapeutic quantity. VesCell is injected either through a coronary artery via catheter, or during surgery, directly into the heart muscle.
A key aspect of VesCell therapy is the advanced cell isolation and expansion technique that allows for the ACPs to be harvested from blood collected in a procedure similar to a common blood donation. VesCell uses a patient’s own adult stem cells to treat Heart Disease and PAD and is a viable therapeutic possibility for heart or PAD patients without any other treatment option.
